A whole-transcriptome analysis of differentially expressed genes, transcripts, and transcript usage in blood samples from Parkinson’s disease patients
Experimental Biology and Medicine · 2026
DOI: 10.3389/ebm.2026.11099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Biology and Medicine, 2026. Verfasst von Sulev Koks und 11 weiteren Autor:innen. Beteiligte Einrichtung: Perron Institute for Neurological and Translational Science, Perth, WA, Australia. Hauptthemen laut MEDLINE: Parkinson Disease, Gene Expression Profiling, Transcriptome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Eesti Teadusagentuur.
Abstract (Originalsprache)
Parkinson’s disease (PD) is a complex neurodegenerative disorder with diverse molecular signatures that extend beyond the central nervous system. Peripheral blood serves as a minimally invasive source of transcriptomic biomarkers reflecting systemic inflammation, mitochondrial dysfunction, lysosomal impairment, and disrupted RNA processing—key pathways involved in PD. Long-read RNA sequencing with Oxford Nanopore Technologies (ONT) offers unprecedented detail of full-length transcripts, alternative isoforms, and RNA modifications, enabling more accurate detection of disease-related transcriptional changes. We conducted high-throughput ONT long-read RNA sequencing on blood samples from 145 individuals, including PD patients and age-matched healthy controls. RNA libraries were prepared using a cDNA-based protocol optimised for high-accuracy PromethION sequencing. Transcriptomes were quantified with ONT-specific pipelines, and analyses of differential gene expression (DGE), differential transcript expression (DEX), differential transcript usage (DTU), and alternative splicing were performed using ONT-aware tools such as DRIMSeq, DEXSeq, and stageR. Pathway enrichment linked disease-related changes to mitochondrial, lysosomal, and vesicle-trafficking pathways. Our analysis identified highly significant PD-associated transcriptional signatures in peripheral blood (SNCA, VPS13C, LRRK2, GRN, STAU1, NPTN, PARK7). Long-read sequencing uncovered extensive isoform-level dysregulation, including novel transcript variants (e.g., BCL2L2-PABPN1, SQSTM1) in pathways relevant to PD, such as autophagy and endolysosomal trafficking. DTU analyses revealed shifts in isoforms of LRRK2 and GBA1, indicating widespread disturbances in RNA processing. Enrichment analysis showed activation of molecular pathways linked to neurodegeneration. This study provides the largest long-read blood transcriptomic dataset in PD to date, demonstrating that ONT sequencing can resolve isoform-level changes and reveal systemic molecular signatures of PD. Our findings support the development of blood-based RNA biomarkers and the establishment of long-read transcriptomics as a transformative approach for genomic pathology in PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Perron Institute for Neurological and Translational Science, Perth, WA, Australia.
- Personalised Medicine Centre, Health Futures Institute, Murdoch University, Perth, WA, Australia.
- Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
- Department of Neurology, North Estonia Medical Centre, Tallinn, Estonia.
- Curtin Medical School, Faculty of Health Sciences, Curtin University, Perth, WA, Australia.
- Curtin Medical Research Institute, Curtin University, Perth, WA, Australia.
Förderung
- Eesti Teadusagentuur
Zitieren
APA
Koks, S., Muldmaa, M., Price, J., Whiley, L., Jakobson, M., Singleton, L., Howting, D., Pfaff, A. L., Chopra, A., Watson, M., Sikk, K., & Taba, P. (2026). A whole-transcriptome analysis of differentially expressed genes, transcripts, and transcript usage in blood samples from Parkinson’s disease patients. Experimental Biology and Medicine. https://doi.org/10.3389/ebm.2026.11099
Vancouver
Koks S, Muldmaa M, Price J, Whiley L, Jakobson M, Singleton L, et al. A whole-transcriptome analysis of differentially expressed genes, transcripts, and transcript usage in blood samples from Parkinson’s disease patients. Experimental Biology and Medicine. 2026. doi:10.3389/ebm.2026.11099
BibTeX
@article{Koks2026,
author = {Koks, Sulev and Muldmaa, Mari and Price, Jack and Whiley, Luke and Jakobson, Maili and Singleton, Lewis and Howting, Denise and Pfaff, Abigail L and Chopra, Abha and Watson, Mark and Sikk, Katrin and Taba, Pille},
title = {A whole-transcriptome analysis of differentially expressed genes, transcripts, and transcript usage in blood samples from Parkinson’s disease patients},
journal = {Experimental Biology and Medicine},
year = {2026},
doi = {10.3389/ebm.2026.11099}
}
EUVIMED